Related references
Note: Only part of the references are listed.The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells
Rajiv Sharma et al.
NATURE COMMUNICATIONS (2021)
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
Samuele Ferrari et al.
NATURE BIOTECHNOLOGY (2020)
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
Giulia Schiroli et al.
CELL STEM CELL (2019)
Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination
Renata M. Martin et al.
CELL STEM CELL (2019)
Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
So Hyun Park et al.
NUCLEIC ACIDS RESEARCH (2019)
Gene correction for SCID-X1 in long-term hematopoietic stem cells
Mara Pavel-Dinu et al.
NATURE COMMUNICATIONS (2019)
CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
Lei Xu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods
Sowmya Pattabhi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
Natalia Gomez-Ospina et al.
NATURE COMMUNICATIONS (2019)
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent β-thalassemia
Sarah Marktel et al.
NATURE MEDICINE (2019)
Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells
M. Kyle Cromer et al.
MOLECULAR THERAPY (2018)
CRISPR/Cas9 genome editing in human hematopoietic stem cells
Rasmus O. Bak et al.
NATURE PROTOCOLS (2018)
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
A. A. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting
Carsten T. Charlesworth et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease
Suk See De Ravin et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1
Giulia Schiroli et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors
Rasmus O. Bak et al.
CELL REPORTS (2017)
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
Rasmus O Bak et al.
eLife (2017)
Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors
Brian M. Dulmovits et al.
BLOOD (2016)
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-Globin Gene
Olivier Negre et al.
HUMAN GENE THERAPY (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A. DeWitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
α-Globin as a molecular target in the treatment of β-thalassemia
Sachith Mettananda et al.
BLOOD (2015)
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Matthew C. Canver et al.
NATURE (2015)
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel et al.
NATURE BIOTECHNOLOGY (2015)
Easy quantitative assessment of genome editing by sequence trace decomposition
Eva K. Brinkman et al.
NUCLEIC ACIDS RESEARCH (2014)
COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
Thomas J. Cradick et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo
Jingping Hu et al.
BLOOD (2013)
The Molecular Basis of β-Thalassemia
Swee Lay Thein
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients
Laura Breda et al.
PLOS ONE (2012)
Universal Real-Time PCR for the Detection and Quantification of Adeno-Associated Virus Serotype 2-Derived Inverted Terminal Repeat Sequences
Christine Aurnhammer et al.
HUMAN GENE THERAPY METHODS (2012)
FLASH: fast length adjustment of short reads to improve genome assemblies
Tanja Magoc et al.
BIOINFORMATICS (2011)
Rapid separation of human globin chains in normal and thalassemia patients by RP-HPLC
Hooshang Nemati et al.
MOLECULAR BIOLOGY REPORTS (2011)
AAV-mediated gene targeting methods for human cells
Iram F. Khan et al.
NATURE PROTOCOLS (2011)
The impact of single gene and chromosomal disorders on hospital admissions in an adult population
Danielle E. Dye et al.
JOURNAL OF COMMUNITY GENETICS (2011)
Comparison of human cord blood engraftment between immunocompromised mouse strains
Sean P. McDermott et al.
BLOOD (2010)
AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3
M. Wunderlich et al.
LEUKEMIA (2010)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Beta-thalassemia
Renzo Galanello et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
Graft rejection after unrelated donor hematopoietic stera cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction
K Fleischhauer et al.
BLOOD (2006)
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
G Puthenveetil et al.
BLOOD (2004)
Prospects for research in hematologic disorders - Sickle cell disease and thalassemia
WC Mentzer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Long-term survive of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation
M Andreani et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
